EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Flurpiridaz F 18: First Approval

Susan J Keam

American Journal of Cardiovascular Drugs · 2025-01 · 25 (1) · 1-6

DOI: 10.1007/s40256-024-00718-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Cardiovascular Drugs, online erschienen am 25.01.2025. Verfasst von Susan J Keam. Beteiligte Einrichtung: Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. cvd@adis.com. Hauptthemen laut MEDLINE: Myocardial Perfusion Imaging, Positron-Emission Tomography, Coronary Artery Disease, Radiopharmaceuticals. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flurpiridaz F 18 (FLYRCADO™) is an intravenous (IV) radioactive diagnostic drug being developed by GE Healthcare and Lantheus Medical Imaging for use in positron emission tomography (PET) myocardial perfusion imaging (MPI) to detect coronary artery disease (CAD). In September 2024, flurpiridaz F 18 was approved in the USA for PET MPI under rest or stress (pharmacologic or exercise) in adult patients with known or suspected CAD to evaluate for myocardial ischemia and infarction. This article summarizes the milestones in the development of flurpiridaz F 18 leading to this first approval for use in PET MPI in adult patients to evaluate for myocardial ischemia and infarction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Perfusion ImagingPositron-Emission TomographyCoronary Artery DiseaseRadiopharmaceuticalsHumansDrug ApprovalUnited StatesMyocardial InfarctionUnited States Food and Drug AdministrationMyocardial IschemiaPyridazines

Substanzen

RadiopharmaceuticalsBMS 747158-02Pyridazines

Autor:innen und Institutionen

  • Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. cvd@adis.com.

Zitieren

APA

Keam, S. J. (2025). Flurpiridaz F 18: First Approval. American Journal of Cardiovascular Drugs, 25(1), 1-6. https://doi.org/10.1007/s40256-024-00718-5

Vancouver

Keam SJ. Flurpiridaz F 18: First Approval. American Journal of Cardiovascular Drugs. 2025;25(1):1-6. doi:10.1007/s40256-024-00718-5

BibTeX
@article{Keam2025,
  author = {Keam, Susan J},
  title = {Flurpiridaz F 18: First Approval},
  journal = {American Journal of Cardiovascular Drugs},
  year = {2025},
  volume = {25},
  number = {1},
  pages = {1--6},
  doi = {10.1007/s40256-024-00718-5}
}
Kostenlos starten →